- Red, Green
- Decision Date:
- March 2021
Can be promoted as self-care - see self-care policy
- Tablets - 1st line NSAID, low CV risk if daily dose 1200mg or below
- Gel - Ibuprofen 5% gel. Fenbid is the preferred cost effective brand. (Decision date - November 2019). Refer to MSK chapter in primary care formulary and Management of Osteoarthritis.
Reddy’s Laboratories (UK) Limited IV Preparation